Blue Cross Blue Shield of Michigan reportedly plans to drop coverage of GLP-1 obesity drugs for certain plans due to concerns ...
Blue Cross Blue Shield of Michigan will drop coverage GLP-1 obesity drugs in fully insured large group commercial plans ...
Morgan Stanley expects the market for GLP-1s to be worth a staggering $105 billion by 2030. Long-term, the opportunity looks ...
SANDERS NOTCHES ANOTHER PHARMA WIN — Senate HELP Chair Bernie Sanders (I-Vt.) scored another win in his latest battle with the drug industry, getting Novo Nordisk’s CEO to agree to testify about his ...
Glaucoma, also known as the "silent thief of sight," is an eye disease that progresses over time, potentially leading to blindness in one or both eyes. The American Glaucoma Research Foundation ...
Semaglutide (Ozempic, Wegovy) and other drugs in its class are widely known for their role in managing type 2 diabetes and suppressing appetite. They may also prove helpful one day in curbing certain ...
Taking a cutting-edge weight-loss drug could help extremely obese patients drop enough pounds to be eligible for bariatric surgery, a new study shows. Patients with extreme obesity -- a BMI of 70 ...
Share on Pinterest Metabolic and bariatric surgery is more effective for long-term weight loss than lifestyle changes and GLP-1 medications like Ozempic, Wegovy, and Zepbound. Nastasic/Getty ...
An army doctor saved the life of a 27-year-old critically ill man onboard a Pune-Chandigarh flight … ...
Last year, Americans spent over $50 billion on weight loss drugs like Ozempic and Wegovy. Their popularity, and their price, are having effects throughout the economy.
Adjust the colors to reduce glare and give your eyes a break. Use one of the services below to sign in to PBS: You've just tried to add this video to My List. But first, we need you to sign in to ...